Clinical Trials Directory

Trials / Completed

CompletedNCT02751411

Effectiveness & Safety of Promelaxin® Microenemas Against Macrogol 4000 P.O. in Chronic Constipation in Children 6-48 Months

Multicenter, Prospective, Comparative, Randomized Controlled Clinical Trial to Evaluate the Performance and the Safety of Promelaxin® Micro-enemas Vs. Macrogol 4000 Per os in the Treatment of Functional Chronic Constipation in Children Aged Between 6 and 48 Months.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
158 (actual)
Sponsor
Aboca Spa Societa' Agricola · Industry
Sex
All
Age
6 Months – 48 Months
Healthy volunteers
Not accepted

Summary

The study is aimed at the efficacy and safety evalutation of the study treatments through a 2-weeks study period and the subsequent follow-up-

Detailed description

This multicenter, prospective, randomized, controlled trial will be conducted on 120 infants-children with a diagnosis of chronic functional constipation according to the definition of Criteria of Rome III. The enrolled subjects will be randomized according to an electronically generated randomization list in 2 groups: one group will receive micro-enemas of Promelaxin® (Group A) while the second group will receive Macrogol 4000 per os (Group B) . Children will receive the dedicated treatment for two weeks and then undergo a follow-up period of a maximun of 6 weeks. The hypothesis is that the protective micro-enema will help achieving regular evacuation by its local antinflammatory non-pharmacological action. This hypothesis is based on the finding that local anal inflammation can cause functional constipation due to discomfort and pain during evacuation or by influencing reflexes.

Conditions

Interventions

TypeNameDescription
DEVICEmicro-enema with PromelaxinThe intervention has a lubricating, protective action on the anus and rectum and a balanced osmotic action which elicits the evacuation reflex.
DRUGMacrogol 4000Stool softener

Timeline

Start date
2016-04-18
Primary completion
2019-12-31
Completion
2020-03-17
First posted
2016-04-26
Last updated
2020-05-29

Locations

4 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT02751411. Inclusion in this directory is not an endorsement.